Adverse Drug Reactions
Data on Adverse Drug Reactions Described by T. Sakaeda et al
Published in Drug Week, January 27th, 2012
2012 JAN 27 -- "Adverse event reports (AERs) submitted to the US Food and Drug Administration (FDA) were reviewed to confirm platinum agent-associated adverse events, and to clarify the rank-order of these drugs in terms of susceptibility. After a revision of arbitrary drug names and the deletion of duplicated submissions, AERs involving cisplatin (CDDP), carboplatin (CBDCA), or oxaliplatin (L-OHP) were analyzed," scientists in Kyoto, Japan report.
"Authorized pharmacovigilance tools were used for the quantitative detection of signals, i.e., drug-associated adverse events, including the proportional reporting ratio, the reporting odds ratio, the information...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2012-01-27)
More Articles from Drug Week
- Drug Abuse
Chattanooga Law Firm in Step With Governor Haslam's Public Safety Action Plan - Depression
Data on Depression Discussed by Researchers at School of Public Health - Cancer Therapy
Findings from Johns Hopkins University Advance Knowledge in Cancer Therapy - Drug Development
Findings from Y. Shan and Co-Authors Broaden Understanding of Drug Development - Addiction Medicine
How the brain puts the brakes on the negative impact of cocaine - Biochemistry
Institute of Carcinogenesis Describes Research in Biochemistry - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
